Reimagining what has gone before to create lateral flow test devices that are simpler to use

At Atomo Diagnostics we are transforming rapid diagnostic testing (RDT) through the design and manufacture of innovative blood-based medical devices that have won the respect of frontline healthcare providers worldwide for their usability, reliability and safety.

Professional Use – POCT – Self-Test – OTC

awards-2

NG Test Blood Precision hCG

Award-winning integrated HIV tests

The innovative, user-centred design of the AtomoRapid™ HIV professional use removes the need for multiple test components by integrating them into the device platform – greatly simplifying the test procedure, reducing user errors and improving test accuracy.

Find out more >

Custom device development

Compatible with many different assay formats that utilise blood, Atomo’s patented all-in-one device platforms provide a low-risk, cost-effective commercialisation pathway for OEM partners to launch new diagnostic test applications or enhance their existing RDT product offerings.

Learn more >

Supporting better Global Health outcomes

Recognised by key global health partners for the contribution the company is making to supporting early diagnosis of HIV, as well as its commitment to simplicity in device design, Atomo is spearheading the development of the next generation of HIV self-test products.

Discover more >

shield2

Built-in safety

Auto-retracting lancet activates on contact to lock the needle inside the device for safe disposal, preventing hazardous sharps injuries and the risk of cross-infection.

thumbsup

Easy to use

Easy to use blood collection unit is designed to collect exactly the right sample volume, improving patient comfort and ensuring optimal test performance.

Excellent Quality

Manufactured to the highest international quality standards, including ISO 9001 and ISO 13485, to ensure excellent product performance and reliability.

 Latest Updates

 Press Release

2301, 2018

Atomo Diagnostics and Access Bio partner to expand access to best-in-class HIV rapid testing in global markets

Sydney, Australia and Seoul, South Korea – 23 January 2018 | Atomo Diagnostics and Access Bio Inc. today announce a [...]

 News

Strategic Partnership Announcement: Atomo Diagnostics and Access Bio

January 23rd, 2018|0 Comments

Today, Atomo Diagnostics and Access Bio Inc. jointly announced a strategic partnership to leverage the respective strengths of both companies and expand point of care HIV testing in global markets. Atomo will supply its award-winning AtomoRapid™ lateral [...]

 Blog

World AIDS Day 2017: Self-testing key to improving early diagnosis of HIV

Written by CEO, John Kelly: As I read the news, on this World AIDS Day, I am heartened to see so many positive and inspiring stories about the progress being made in communities around the [...]